Clemens Alt

Title: Clemens Alt: Innovator in In Vivo Flow Cytometry and Retinal Treatments

Introduction

Clemens Alt is a notable inventor based in Watertown, MA (US), recognized for his contributions to medical technology. He holds a total of 5 patents that focus on advanced methodologies in flow cytometry and retinal treatments. His work has significant implications for both research and clinical applications.

Latest Patents

One of his latest patents is titled "In vivo flow cytometry based on cellular autofluorescence." This invention provides methods and systems for performing in vivo flow cytometry by utilizing blood vessels as flow chambers. This allows for the monitoring of flowing cells in a live subject without the need for blood sample withdrawal. The invention employs multi-photon excitation of an exogenous fluorophore or utilizes endogenous cellular fluorescence for analysis.

Another significant patent is "Dose determination for inducing microcavitation in retinal pigment epithelium (RPE)." This patent outlines methods for selectively targeting RPE cells within a treatment region. The process involves depositing energy on a test region of the RPE, determining the extent of microcavitation, and adjusting energy deposition based on the results.

Career Highlights

Clemens Alt is affiliated with The General Hospital Corporation, where he continues to innovate in the field of medical technology. His work has contributed to advancements in non-invasive diagnostic techniques and targeted therapies.

Collaborations

Clemens has collaborated with notable colleagues, including Charles P Lin and Alicia L Carlson, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Clemens Alt's innovative work in in vivo flow cytometry and retinal treatments showcases his commitment to advancing medical technology. His patents reflect a deep understanding of cellular processes and a dedication to improving patient care.